Wójcikowski C, Maier V, Dominiak K, Fussgänger R, Pfeiffer E F
Diabetologia. 1983 Sep;25(3):288-90. doi: 10.1007/BF00279945.
The effects of synthetic rat C-peptide 1 and C-peptide 2 on plasma insulin and blood glucose concentrations in the rat were studied. Infusion of rat C-peptide (500 micrograms X h-1 X kg-1) diminished glucose induced increase of plasma insulin by 56% (15.2 +/- 0.9 versus 6.6 +/- 0.6 ng/ml, p less than 0.01, mean +/- SEM). Somatostatin infused at a rate of 50 micrograms X h-1 X kg-1 body weight inhibited glucose-induced insulin secretion by 33%. In the presence of a mixture of both C-peptides or somatostatin, blood glucose after intravenous glucose was higher than in the control experiments. In alloxan-diabetic rats, C-peptide (160 micrograms/kg) significantly increased and prolonged the hypoglycaemic effect of exogenous insulin. It is suggested that C-peptide may not be a biologically inert substance.
研究了合成大鼠C肽1和C肽2对大鼠血浆胰岛素和血糖浓度的影响。输注大鼠C肽(500微克×小时-1×千克-1)可使葡萄糖诱导的血浆胰岛素增加减少56%(15.2±0.9对6.6±0.6纳克/毫升,p<0.01,平均值±标准误)。以50微克×小时-1×千克-1体重的速率输注生长抑素可抑制葡萄糖诱导的胰岛素分泌33%。在同时存在两种C肽或生长抑素的混合物时,静脉注射葡萄糖后的血糖高于对照实验。在四氧嘧啶糖尿病大鼠中,C肽(160微克/千克)显著增强并延长外源性胰岛素的降血糖作用。提示C肽可能不是一种生物惰性物质。